Diagnostic Radiology in New Braunfels, TX
5 verified diagnostic radiology doctors in New Braunfels.
Radiologists interpret medical imaging such as X-rays, CT, MRI, and ultrasound to diagnose disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. James Flournoy, MD
Diagnostic Radiology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Fernando Bazan, MD
Diagnostic Radiology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Lowe, MD
Diagnostic Radiology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Osborne, MD
Diagnostic Radiology
CMS Open Payments· $18.68 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$18.68
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 45,487 diagnostic radiology doctors we've analyzed, about 22% received any industry payment (median $144 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US diagnostic radiology doctors.
Payments to John Osborne do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Milbourn, MD
Diagnostic Radiology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.